Latest TANG CAPITAL MANAGEMENT LLC Stock Portfolio
TANG CAPITAL MANAGEMENT LLC Performance:
2024 Q3: 4.62%YTD: 6.19%2023: -10.95%
Performance for 2024 Q3 is 4.62%, and YTD is 6.19%, and 2023 is -10.95%.
About TANG CAPITAL MANAGEMENT LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, TANG CAPITAL MANAGEMENT LLC reported an equity portfolio of $1.4 Billions as of 30 Sep, 2024.
The top stock holdings of TANG CAPITAL MANAGEMENT LLC are EOLS, TARS, AUPH. The fund has invested 5.6% of it's portfolio in EVOLUS INC and 5.3% of portfolio in TARSUS PHARMACEUTICALS INC.
The fund managers got completely rid off ELI LILLY & CO (LLY), INHIBRX BIOSCIENCES INC and DOUGLAS EMMETT INC (DEI) stocks. They significantly reduced their stock positions in SERES THERAPEUTICS INC (MCRB), RELMADA THERAPEUTICS INC (RLMD) and ENANTA PHARMACEUTICALS INC (ENTA). TANG CAPITAL MANAGEMENT LLC opened new stock positions in BIONTECH SE, RELAY THERAPEUTICS INC (RLAY) and ITEOS THERAPEUTICS INC (ITOS). The fund showed a lot of confidence in some stocks as they added substantially to GALAPAGOS NV, REVANCE THERAPEUTICS INC (RVNC) and ABCELLERA BIOLOGICS INC (ABCL).
The top stock holdings of TANG CAPITAL MANAGEMENT LLC are EOLS, TARS, AUPH. The fund has invested 5.6% of it's portfolio in EVOLUS INC and 5.3% of portfolio in TARSUS PHARMACEUTICALS INC.
The fund managers got completely rid off ELI LILLY & CO (LLY), INHIBRX BIOSCIENCES INC and DOUGLAS EMMETT INC (DEI) stocks. They significantly reduced their stock positions in SERES THERAPEUTICS INC (MCRB), RELMADA THERAPEUTICS INC (RLMD) and ENANTA PHARMACEUTICALS INC (ENTA). TANG CAPITAL MANAGEMENT LLC opened new stock positions in BIONTECH SE, RELAY THERAPEUTICS INC (RLAY) and ITEOS THERAPEUTICS INC (ITOS). The fund showed a lot of confidence in some stocks as they added substantially to GALAPAGOS NV, REVANCE THERAPEUTICS INC (RVNC) and ABCELLERA BIOLOGICS INC (ABCL).
TANG CAPITAL MANAGEMENT LLC Annual Return Estimates Vs S&P 500
Our best estimate is that TANG CAPITAL MANAGEMENT LLC made a return of 4.62% in the last quarter. In trailing 12 months, it's portfolio return was 20.43%.
New Buys
| Ticker | $ Bought |
|---|---|
| biontech se | 32,067,900 |
| relay therapeutics inc | 25,261,900 |
| iteos therapeutics inc | 24,583,600 |
| neurocrine biosciences inc | 17,283,000 |
| novavax inc | 12,630,000 |
| corbus pharmaceuticals hldgs | 12,378,000 |
| elanco animal health inc | 8,814,000 |
| hillevax inc | 8,659,200 |
New stocks bought by TANG CAPITAL MANAGEMENT LLC
Additions
| Ticker | % Inc. |
|---|---|
| galapagos nv | 1,158 |
| lava therapeutics nv | 939 |
| revance therapeutics inc | 525 |
| abcellera biologics inc | 398 |
| intel corp | 397 |
| disney walt co | 335 |
| verizon communications inc | 284 |
| exxon mobil corp | 267 |
Additions to existing portfolio by TANG CAPITAL MANAGEMENT LLC
Reductions
| Ticker | % Reduced |
|---|---|
| seres therapeutics inc | -91.69 |
| relmada therapeutics inc | -78.63 |
| enanta pharmaceuticals inc | -57.78 |
| verastem inc | -50.14 |
| athira pharma inc | -43.00 |
| beam therapeutics inc | -37.04 |
| bioatla inc | -36.39 |
| dynavax technologies corp | -24.00 |
TANG CAPITAL MANAGEMENT LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| mirum pharmaceuticals inc | -2,831,980 |
| adaptimmune therapeutics plc | -1,699,850 |
| quince therapeutics inc | -1,125,000 |
| douglas emmett inc | -2,277,850 |
| inhibrx biosciences inc | -2,373,480 |
| journey med corp | -836,536 |
| aligos therapeutics inc | -577,500 |
| eli lilly & co | -24,445,300 |
TANG CAPITAL MANAGEMENT LLC got rid off the above stocks
Sector Distribution
TANG CAPITAL MANAGEMENT LLC has about 81.5% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 81.5 |
| Others | 14.7 |
| Technology | 1.5 |
| Communication Services | 1.2 |
Market Cap. Distribution
TANG CAPITAL MANAGEMENT LLC has about 6.8% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 52.6 |
| UNALLOCATED | 17.2 |
| MID-CAP | 14.1 |
| MICRO-CAP | 8.1 |
| MEGA-CAP | 3.6 |
| LARGE-CAP | 3.2 |
| NANO-CAP | 1.3 |
Stocks belong to which Index?
About 70% of the stocks held by TANG CAPITAL MANAGEMENT LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 65.5 |
| Others | 30 |
| S&P 500 | 4.5 |
TANG CAPITAL MANAGEMENT LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of TANG CAPITAL MANAGEMENT LLC
TANG CAPITAL MANAGEMENT LLC has 154 stocks in it's portfolio. About 35.9% of the portfolio is in top 10 stocks. CRBP proved to be the most loss making stock for the portfolio. EOLS was the most profitable stock for TANG CAPITAL MANAGEMENT LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABCL | abcellera biologics inc | 0.43 | 2,300,000 | 5,980,000 | added | 398 | ||
| ACAD | acadia pharmaceuticals inc | 1.65 | 1,500,000 | 23,070,000 | unchanged | 0.00 | ||
| ACET | adicet bio inc | 0.84 | 8,216,960 | 11,832,400 | unchanged | 0.00 | ||
| ADAP | adaptimmune therapeutics plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ADGI | invivyd inc | 0.02 | 330,172 | 336,775 | added | 65.09 | ||
| ALGS | aligos therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALL | allstate corp | 0.02 | 1,260 | 239,027 | unchanged | 0.00 | ||
| ALLK | allakos inc | 0.00 | 45,262 | 29,565 | new | |||
| ALT | altimmune inc | 1.21 | 2,750,000 | 16,885,000 | unchanged | 0.00 | ||
| ALXO | alx oncology hldgs inc | 0.55 | 4,204,740 | 7,652,620 | new | |||
| AMLX | amylyx pharmaceuticals inc | 0.02 | 100,000 | 324,000 | unchanged | 0.00 | ||
| AMZN | amazon com inc | 0.01 | 1,164 | 216,842 | unchanged | 0.00 | ||
| ANAB | anaptysbio inc | 3.18 | 1,330,880 | 44,584,400 | unchanged | 0.00 | ||
| ANIP | ani pharmaceuticals inc | 1.92 | 450,000 | 26,847,000 | unchanged | 0.00 | ||
| APLT | applied therapeutics inc | 1.66 | 2,730,000 | 23,205,000 | added | 17.17 | ||
| ARE | alexandria real estate eq in | 0.34 | 40,000 | 4,750,000 | unchanged | 0.00 | ||
| ARVN | arvinas inc | 0.32 | 180,000 | 4,433,400 | unchanged | 0.00 | ||
| ATHA | athira pharma inc | 0.02 | 600,000 | 267,600 | reduced | -43.00 | ||
| ATRA | atara biotherapeutics inc | 0.04 | 75,196 | 611,343 | unchanged | 0.00 | ||
| ATXS | astria therapeutics inc | 0.08 | 100,000 | 1,101,000 | unchanged | 0.00 | ||